thymopentin has been researched along with Acute Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Klusha, VIe; Neporada, KS; Skrypnyk, IM; Tarasenko, LM | 1 |
| Arione, R; Cadario, G; Icardi, M; Megale, N; Valenzano, C | 1 |
2 other study(ies) available for thymopentin and Acute Disease
| Article | Year |
|---|---|
[The typological characteristics of the stress activation of lipid peroxidation and its correction by thymopentin].
Topics: Acute Disease; Adjuvants, Immunologic; Animals; Disease Models, Animal; Drug Evaluation, Preclinical; Lipid Peroxidation; Male; Rats; Rats, Wistar; Stress, Physiological; Thymopentin | 1997 |
[The use of thymopentin in preventing acute infectious relapses in elderly subjects with COPD].
Topics: Acute Disease; Aged; Aged, 80 and over; Drug Evaluation; Female; Humans; Leukocyte Count; Lung Diseases, Obstructive; Male; Recurrence; Respiratory Tract Infections; Thymopentin; Time Factors | 1992 |